Phenylephrine hydrochloride (PE) is a post-synaptic α-receptor agonist, with low
cardioselective β-receptor affinity. It has a recognised decongestant activity, by
vasoconstriction, to reduce oedema of the nasal mucosa. α-adrenergic receptors are
found on pre- and post-capillary blood vessels in the nasal mucosa, stimulation of
which causes constriction of vascular smooth muscle. As a consequence, nasal blood
flow is reduced leading to a reduction in nasal mucosal swelling. The tablets are
indicated to relieve nasal congestion associated with colds and hayfever.
The Phenylephrine Hydrochloride market revenue was xx Million USD in 2016, grew to xx Million USD in 2021, and will reach xx Million USD in 2026, with a CAGR of xx during 2021-2026.

Considering the influence of COVID-19 on the global Phenylephrine Hydrochloride market, this report analyzed the impact from both global and regional perspectives. From production end to consumption end in regions such as North America, Europe, China, and Japan, the report put emphasis on analysis of market under COVID-19 and corresponding response policy in different regions.

This report also analyzes the strategies for different companies to deal with the impact of COVID-19 in detail to seek a path to recovery.

Under COVID-19 Outbreak, how the Phenylephrine Hydrochloride Industry will develop is also analyzed in detail in Chapter 1.8 of this report.

Major Players in Phenylephrine Hydrochloride market are:
Shenzhen Oriental Pharma
SNA Health Care
Chifeng Arker Pharma
ZEON Pharma
Cornileus Pharmaceuticals
Arch Pharmalabs
Surya Life Sciences

Most important types of Phenylephrine Hydrochloride products covered in this report are:
Eye drops
Tablet
Others

Most widely used downstream fields of Phenylephrine Hydrochloride market covered in this report are:
Government Hospitals
Private Hospitals and Clinics
Healthcare organizations
Others

Major Region

s or countries covered in this report:
North America
Europe
China
Japan
Middle East and Africa
South America
India
South Korea
Southeast Asia
Others

In Chapter 3.4, the report provides analysis of the reasons behind price fluctuations.

In chapters 5, 6, and 7, the impact of COVID-19 on the different regions in both production and consumption end and SWOT analysis are pointed out.

In Chapters 8, the report presents company's recent development and strategies to deal with the impact of COVID-19.

Years considered for this report:

Historical Years:

2016-2020

Base Year:

2020

Estimated Year:

2021

Forecast Period:

2021-2026